Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.32
GB's Cash to Debt is ranked higher than
53% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. GB: 0.32 )
GB' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.32

Equity to Asset 0.64
GB's Equity to Asset is ranked higher than
69% of the 447 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. GB: 0.64 )
GB' s 10-Year Equity to Asset Range
Min: 0.28   Max: 0.75
Current: 0.64

0.28
0.75
Interest Coverage 5.45
GB's Interest Coverage is ranked lower than
53% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 231.38 vs. GB: 5.45 )
GB' s 10-Year Interest Coverage Range
Min: 0.05   Max: 9.31
Current: 5.45

0.05
9.31
F-Score: 8
Z-Score: 3.85
M-Score: -2.76
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 10.24
GB's Operating margin (%) is ranked higher than
83% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. GB: 10.24 )
GB' s 10-Year Operating margin (%) Range
Min: 0.2   Max: 17.66
Current: 10.24

0.2
17.66
Net-margin (%) 7.35
GB's Net-margin (%) is ranked higher than
82% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. GB: 7.35 )
GB' s 10-Year Net-margin (%) Range
Min: -2.87   Max: 10.76
Current: 7.35

-2.87
10.76
ROE (%) 9.07
GB's ROE (%) is ranked higher than
81% of the 445 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. GB: 9.07 )
GB' s 10-Year ROE (%) Range
Min: -2.39   Max: 10.53
Current: 9.07

-2.39
10.53
ROA (%) 5.66
GB's ROA (%) is ranked higher than
81% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. GB: 5.66 )
GB' s 10-Year ROA (%) Range
Min: -1.07   Max: 6.21
Current: 5.66

-1.07
6.21
ROC (Joel Greenblatt) (%) 22.34
GB's ROC (Joel Greenblatt) (%) is ranked higher than
82% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. GB: 22.34 )
GB' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 0.38   Max: 52.65
Current: 22.34

0.38
52.65
Revenue Growth (3Y)(%) 5.40
GB's Revenue Growth (3Y)(%) is ranked higher than
75% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. GB: 5.40 )
GB' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.2   Max: 30.3
Current: 5.4

0.2
30.3
EBITDA Growth (3Y)(%) -4.50
GB's EBITDA Growth (3Y)(%) is ranked higher than
71% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. GB: -4.50 )
GB' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -7.6   Max: 30.6
Current: -4.5

-7.6
30.6
EPS Growth (3Y)(%) 1.00
GB's EPS Growth (3Y)(%) is ranked higher than
74% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. GB: 1.00 )
GB' s 10-Year EPS Growth (3Y)(%) Range
Min: -20   Max: 146.6
Current: 1

-20
146.6
» GB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

GB Guru Trades in Q4 2013

Steven Cohen 201,440 sh (+1762.6%)
Jim Simons 23,100 sh (+143.16%)
Chuck Royce 83,000 sh (+1.22%)
Paul Tudor Jones Sold Out
Diamond Hill Capital 614,570 sh (-1.37%)
Mario Gabelli 250,600 sh (-9.73%)
» More
Q1 2014

GB Guru Trades in Q1 2014

Joel Greenblatt 138,990 sh (New)
Jim Simons 112,290 sh (+386.1%)
Steven Cohen Sold Out
Mario Gabelli 243,600 sh (-2.79%)
Chuck Royce 70,000 sh (-15.66%)
Diamond Hill Capital 504,785 sh (-17.86%)
» More
Q2 2014

GB Guru Trades in Q2 2014

Joel Greenblatt 250,635 sh (+80.33%)
Chuck Royce 107,000 sh (+52.86%)
Jim Simons 161,300 sh (+43.65%)
Mario Gabelli 227,100 sh (-6.77%)
Diamond Hill Capital 414,221 sh (-17.94%)
» More
Q3 2014

GB Guru Trades in Q3 2014

Paul Tudor Jones 18,514 sh (New)
Ken Fisher 609,572 sh (New)
Joel Greenblatt 264,417 sh (+5.5%)
Diamond Hill Capital 411,516 sh (-0.65%)
Mario Gabelli 194,100 sh (-14.53%)
Jim Simons 107,100 sh (-33.6%)
Chuck Royce 60,408 sh (-43.54%)
» More
» Details

Insider Trades

Latest Guru Trades with GB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2014-09-30 New Buy0.06%$42.95 - $51 $ 48.834%609572
Joel Greenblatt 2014-06-30 Add 80.33%0.07%$44.4 - $49.94 $ 48.834%250635
Joel Greenblatt 2014-03-31 New Buy0.1%$40.37 - $46.98 $ 48.8311%138990
Joel Greenblatt 2012-06-30 Sold Out 0.09%$20.5 - $24.73 $ 48.83120%0
Joel Greenblatt 2012-03-31 Reduce -22.75%0.03%$21.51 - $25.49 $ 48.83119%41455
Mario Gabelli 2012-03-31 Add 53.3%0.02%$21.51 - $25.49 $ 48.83119%320400
Joel Greenblatt 2011-12-31 Add 21.58%0.02%$18.86 - $22.74 $ 48.83132%53665
Joel Greenblatt 2011-09-30 Add 49.86%0.05%$19.19 - $28.2 $ 48.83112%44139
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 24.70
GB's P/E(ttm) is ranked higher than
88% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 85.90 vs. GB: 24.70 )
GB' s 10-Year P/E(ttm) Range
Min: 11.04   Max: 575.08
Current: 24.7

11.04
575.08
P/B 2.04
GB's P/B is ranked higher than
83% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.88 vs. GB: 2.04 )
GB' s 10-Year P/B Range
Min: 0.97   Max: 3.95
Current: 2.04

0.97
3.95
P/S 1.82
GB's P/S is ranked higher than
80% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. GB: 1.82 )
GB' s 10-Year P/S Range
Min: 0.78   Max: 4.47
Current: 1.82

0.78
4.47
PFCF 16.84
GB's PFCF is ranked higher than
93% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 16.84 )
GB' s 10-Year PFCF Range
Min: 6.12   Max: 169.91
Current: 16.84

6.12
169.91
EV-to-EBIT 18.98
GB's EV-to-EBIT is ranked higher than
88% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 64.69 vs. GB: 18.98 )
GB' s 10-Year EV-to-EBIT Range
Min: 8.3   Max: 3207.3
Current: 18.98

8.3
3207.3
PEG 3.06
GB's PEG is ranked higher than
92% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 3.06 )
GB' s 10-Year PEG Range
Min: 0.71   Max: 920.69
Current: 3.06

0.71
920.69
Shiller P/E 51.17
GB's Shiller P/E is ranked higher than
86% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 51.17 )
GB' s 10-Year Shiller P/E Range
Min: 22.95   Max: 61.71
Current: 51.17

22.95
61.71
Current Ratio 3.63
GB's Current Ratio is ranked higher than
78% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. GB: 3.63 )
GB' s 10-Year Current Ratio Range
Min: 1.6   Max: 8.42
Current: 3.63

1.6
8.42
Quick Ratio 2.20
GB's Quick Ratio is ranked higher than
72% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. GB: 2.20 )
GB' s 10-Year Quick Ratio Range
Min: 0.79   Max: 6.93
Current: 2.2

0.79
6.93

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 7.93
GB's Price/Tangible Book is ranked higher than
66% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 6.71 vs. GB: 7.93 )
GB' s 10-Year Price/Tangible Book Range
Min: 5.43   Max: 74.81
Current: 7.93

5.43
74.81
Price/DCF (Projected) 1.37
GB's Price/DCF (Projected) is ranked higher than
94% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 1.37 )
GB' s 10-Year Price/DCF (Projected) Range
Min: 0.52   Max: 1.73
Current: 1.37

0.52
1.73
Price/Median PS Value 1.37
GB's Price/Median PS Value is ranked higher than
66% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. GB: 1.37 )
GB' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 3.99
Current: 1.37

0.6
3.99
Price/Peter Lynch Fair Value 3.13
GB's Price/Peter Lynch Fair Value is ranked higher than
95% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 3.13 )
GB' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.74   Max: 88.62
Current: 3.13

0.74
88.62
Price/Graham Number 2.89
GB's Price/Graham Number is ranked higher than
83% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. GB: 2.89 )
GB' s 10-Year Price/Graham Number Range
Min: 1.97   Max: 14.44
Current: 2.89

1.97
14.44
Earnings Yield (Greenblatt) 5.30
GB's Earnings Yield (Greenblatt) is ranked higher than
88% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. GB: 5.30 )
GB' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 12
Current: 5.3

0.1
12
Forward Rate of Return (Yacktman) 12.07
GB's Forward Rate of Return (Yacktman) is ranked higher than
86% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.50 vs. GB: 12.07 )
GB' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.6   Max: 27
Current: 12.07

3.6
27

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WGB.Germany,
Greatbatch, Inc is a Delaware corporation was incorporated on July 11, 1997. The Company designs and manufactures critical components that help to advance medical device technology across various applications. The Company operates in two segments namely Greatbatch Medical and QiG Group. Greatbatch Medical designs and manufactures products where Greatbatch either owns the intellectual property or has unique manufacturing and assembly expertise. Its products include medical devices and components for the cardiac, neuromodulation, orthopaedics, portable medical, vascular and energy markets among others. The Greatbatch Medical segment also offers value-added assembly and design engineering services for medical devices that utilize its component products.. QiG segment develops medical device systems for some of healthcare's challenges and reflects Greatbatch's strategic evolution of its product offerings. Through the research and development professionals in QiG, the Company is now investing in three areas namely new medical device systems commercialization, collaborative programs with OEM customers, and strategic equity positions in start-up companies to grow a diversified and distinctive portfolio. The medical device systems developed by QiG are manufactured by Greatbatch Medical. The Company's customers include large multi-national original equipment manufacturers. The Company is subject to direct governmental regulation including the laws and regulations generally applicable to all businesses in the jurisdictions in which it operates.
» More Articles for GB

Headlines

Articles On GuruFocus.com
BlackBerry Seems To Be Making The Right Moves Mar 08 2014 
Diamond Hill Capital Buys EOG, BR, GB, TEVA, BGS, IWD, HCC Jan 20 2011 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 09 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 10 2010 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2010 
Greatbatch Inc. Reports Operating Results (10-Q) Nov 10 2009 
Greatbatch Inc. Reports Operating Results (10-Q) Aug 11 2009 
Greatbatch, Inc. Reports Second Quarter 2009 Results Aug 04 2009 
Greatbatch Inc. Reports Operating Results (10-Q) May 12 2009 

More From Other Websites
GREATBATCH, INC. Financials Nov 19 2014
10-Q for Greatbatch, Inc. Nov 14 2014
GREATBATCH, INC. Files SEC form 10-Q, Quarterly Report Nov 12 2014
Greatbatch Beats Q3 Earnings Estimates; Upgrades '14 View Oct 31 2014
Greatbatch beats 3Q profit forecasts Oct 31 2014
Greatbatch beats 3Q profit forecasts Oct 31 2014
Greatbatch Inc Earnings Call scheduled for 5:00 pm ET today Oct 30 2014
Greatbatch, Inc. Reports 2014 Third Quarter Results Oct 30 2014
GREATBATCH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 30 2014
Greatbatch, Inc. Reports 2014 Third Quarter Results Oct 30 2014
Q3 2014 Greatbatch Inc Earnings Release - After Market Close Oct 30 2014
Greatbatch, Inc. to Host Q3 2014 Earnings Conference Call Oct 14 2014
GREATBATCH, INC. Files SEC form 8-K, Change in Directors or Principal Officers Sep 25 2014
Greatbatch to See Sluggish Top Line Growth Aug 27 2014
Greatbatch Slips to Sell on Weak Q2 Aug 25 2014
Greatbatch Acquires Uruguay-based CCC Medical Devices Aug 13 2014
GREATBATCH, INC. Files SEC form 10-Q, Quarterly Report Aug 12 2014
Greatbatch Meets on Q2 Earnings, Misses on Revenues Aug 01 2014
GREATBATCH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 31 2014
Deutsche Bank's 4 Favorite Stocks In Aerospace & Defense Jul 09 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK